One Stop Solution For In-Depth Market Research Reports

詳細な市場調査レポートのワンストップソリューション

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Immunofluorescence Assay Market

[ 英語タイトル ] Immunofluorescence Assay Market by Product (Reagent, Primary & Secondary Antibody, Kit, Imaging Equipment, Immunofluorescence Microscopy), Type (Direct, Indirect), Disease (Cancer, Cardiovascular, Infectious Disease) & End User - Global Forecast to 2023


Product Code : MNMHC00109448
Survey : MarketsandMarkets
Publish On : February, 2021
Category : Healthcare and Pharmaceuticals
Study Area : Global
Report format : PDF
Sales price option (consumption tax not included)
Single User USD5650 / Question Form
5 User USD6650 / Question Form
Enterprise User USD10000 / Question Form

[Report Description]

“The global immunofluorescence assay market projected to grow at a CAGR of 5.8%.”
The immunofluorescence assay market is expected to reach USD 2.01 billion by 2023 from an estimated USD 1.51 billion in 2018, at a CAGR of 5.8%. The increasing prevalence of chronic diseases, increasing R&D spending, and increasing healthcare expenditure are the major factors driving the growth of the significant growth drivers of the immunofluorescence assay market. However, high cost of instruments and implementation of excise duty by the US government are expected to limit the growth of immunofluorescence assay market during the forecast period.

“The kits segment is expected to register the highest CAGR during the forecast period.”
On the basis of product, the immunofluorescence assay market is segmented into reagents, instruments, antibodies, kits, and consumables & accessories. The kits segment is expected to register the highest CAGR during the forecast period. The growth of this segment is primarily attributed to the increasing demand for complete solutions from a single-provider, the rising prevalence of a number of diseases, increasing R&D spending, and increased government funding for life science research.

“Indirect immunofluorescence segment dominated the market in 2017”
On the basis of type, the immunofluorescence assay market is segmented into indirect and direct immunofluorescence. The indirect immunofluorescence segment accounted for the largest share and it is also expected to register the highest CAGR during the forecast period. Factors contributing for its high growth include its advantages over direct immunofluorescence, such as sensitivity, flexibility, and lower cost.

“Cancer segment dominated the market in 2017”
Based on disease, the immunofluorescence assay market is segmented into cancer, infectious diseases, cardiovascular diseases, autoimmune diseases, and other diseases (kidney diseases, neurological diseases, skin diseases, gastrointestinal diseases, and oral diseases). In 2017, the cancer segment accounted for the largest share in the global immunofluorescence assay market owing to the increasing prevalence of cancer across the globe and the widespread adoption of immunofluorescence techniques for the study and diagnosis of cancer.

“Hospitals and Diagnostics is expected to grow at the fastest rate during the forecast period”
On the basis of end user, the immunofluorescence assay market is segmented into pharmaceutical and biotechnology companies, academic and research institutes, hospitals and diagnostics centers, and contract research organizations (CROs). The hospitals and diagnostic centers segment is expected to register the highest CAGR during the forecast period owing to the increasing use of immunofluorescence assay in the diagnose or identify of various diseases.

“APAC is projected to witness the highest growth during the forecast period”
North America held the largest share of the global immunofluorescence assay market in 2017. On the other hand, the APAC region is expected to witness the highest CAGR during the forecast period, owing to the increasing R&D spending, rising prevalence of diseases, large population in countries such as China and India, improving healthcare infrastructure, increasing healthcare spending, and government initiatives in this region.

Break of primary participants was as mentioned below:
• By Company Type – Tier 1–35%, Tier 2–40% and Tier 3–25%
• By Designation – C-level–33%, Director Level–41%, Others–26%
• By Region – North America–35%, Europe–30%, Asia Pacific–21%, Rest of World–14%

The prominent players in the global immunofluorescence assay market are Thermo Fisher (US), Inova Diagnostics (US), Bio-Rad (US), Abcam (UK), PerkinELmer (US), Merck Millipore (US), Cell Signaling Technology (US), MEDIPAN GMBH (Germany), Sino Biological (China), Danaher (US), and Vector Laboratories (US).
Research Coverage:
The report analyzes the various immunofluorescence assay products and their adoption pattern. It aims at estimating the market size and future growth potential of the global immunofluorescence assay market for different segments such as product, type, disease, end user, and region. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening the market.

This report provides insights on the following pointers:
• Market Penetration: Comprehensive information on product portfolios offered by the top players in the global immunofluorescence assay market
• Product Development/Innovation: Detailed insights on upcoming trends, research and development activities and product launches in the global immunofluorescence assay market
• Market Development: Comprehensive information on the lucrative emerging regions by product, type, disease, end user, and region
• Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the global immunofluorescence assay market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and products of leading players in the global immunofluorescence assay market

TABLE OF CONTENTS

1 INTRODUCTION 18
1.1 OBJECTIVES OF THE STUDY 18
1.2 MARKET DEFINITION 18
1.3 MARKET SCOPE 19
1.3.1 MARKETS COVERED 19
1.3.2 YEARS CONSIDERED FOR THE STUDY 19
1.3.3 CURRENCY 20
1.4 STAKEHOLDERS 20
2 RESEARCH METHODOLOGY 21
2.1 RESEARCH APPROACH 21
2.1.1 SECONDARY SOURCES 22
2.1.1.1 Key data from secondary sources 22
2.1.2 PRIMARY SOURCES 22
2.1.2.1 Key data from primary sources 23
2.1.2.2 Key industry insights 24
2.2 MARKET SIZE ESTIMATION 25
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 27
2.4 MARKET SHARE ESTIMATION 28
2.5 ASSUMPTIONS FOR THE STUDY 28
3 EXECUTIVE SUMMARY 29
4 PREMIUM INSIGHTS 33
4.1 IMMUNOFLUORESCENCE ASSAY: MARKET OVERVIEW 33
4.2 IMMUNOFLUORESCENCE ASSAY MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 33
4.3 GEOGRAPHIC SNAPSHOT: IMMUNOFLUORESCENCE ASSAY MARKET (2017) 34
4.4 GEOGRAPHIC MIX: IMMUNOFLUORESCENCE ASSAY MARKET 35
4.5 IMMUNOFLUORESCENCE ASSAY MARKET, BY PRODUCT 35
5 MARKET OVERVIEW 36
5.1 INTRODUCTION 36
5.2 KEY MARKET DYNAMICS 36
5.2.1 MARKET DRIVERS 37
5.2.1.1 Increasing prevalence of chronic diseases 37
5.2.1.2 Increasing R&D spending 38
5.2.1.3 Increasing healthcare spending 39

5.2.2 MARKET RESTRAINTS 39
5.2.2.1 High cost of instruments 39
5.2.2.2 Implementation of excise duty by the US government 40
5.2.3 MARKET OPPORTUNITIES 40
5.2.3.1 High growth opportunities in emerging markets 40
5.2.4 MARKET CHALLENGES 41
5.2.4.1 Quality concerns over research antibodies 41
6 IMMUNOFLUORESCENCE ASSAY MARKET, BY PRODUCT 42
6.1 INTRODUCTION 43
6.2 REAGENTS 44
6.2.1 STAINS & DYES 45
6.2.2 MEDIA & SERA 46
6.2.3 FIXATIVES 47
6.2.4 BUFFERS 48
6.2.5 PROBES 49
6.2.6 SOLVENTS 50
6.2.7 OTHER REAGENTS 51
6.3 INSTRUMENTS 52
6.3.1 MICROSCOPES 54
6.3.2 IMAGING ANALYSIS SYSTEMS 55
6.4 ANTIBODIES 56
6.4.1 PRIMARY ANTIBODIES 57
6.4.2 SECONDARY ANTIBODIES 58
6.5 KITS 59
6.6 CONSUMABLES & ACCESSORIES 60
7 IMMUNOFLUORESCENCE ASSAY MARKET, BY TYPE 62
7.1 INTRODUCTION 63
7.2 INDIRECT IMMUNOFLUORESCENCE 64
7.3 DIRECT IMMUNOFLUORESCENCE 65
8 IMMUNOFLUORESCENCE ASSAY MARKET, BY DISEASE 67
8.1 INTRODUCTION 68
8.2 CANCER 69
8.3 INFECTIOUS DISEASES 70
8.4 CARDIOVASCULAR DISEASES 71
8.5 AUTOIMMUNE DISEASES 72
8.6 OTHER DISEASES 73

9 IMMUNOFLUORESCENCE ASSAY MARKET, BY END USER 75
9.1 INTRODUCTION 76
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 77
9.3 ACADEMIC & RESEARCH INSTITUTES 78
9.4 HOSPITALS & DIAGNOSTIC CENTERS 79
9.5 CONTRACT RESEARCH ORGANIZATIONS 80
10 IMMUNOFLUORESCENCE ASSAY MARKET, BY REGION 81
10.1 INTRODUCTION 82
10.2 NORTH AMERICA 83
10.2.1 US 86
10.2.2 CANADA 90
10.3 EUROPE 93
10.3.1 GERMANY 96
10.3.2 UK 99
10.3.3 FRANCE 103
10.3.4 ITALY 106
10.3.5 SPAIN 109
10.3.6 REST OF EUROPE 112
10.4 ASIA PACIFIC 115
10.4.1 JAPAN 119
10.4.2 CHINA 122
10.4.3 INDIA 125
10.4.4 REST OF ASIA PACIFIC 128
10.5 LATIN AMERICA 131
10.6 MIDDLE EAST AND AFRICA 134
11 COMPETITIVE LANDSCAPE 138
11.1 INTRODUCTION 138
11.2 MARKET LEADERSHIP ANALYSIS 139
11.3 GEOGRAPHIC REVENUE MIX OF THE MAJOR PLAYERS 139
11.4 COMPETITIVE SCENARIO 140
11.4.1 PRODUCT LAUNCHES 140
11.4.2 EXPANSIONS 141
11.4.3 ACQUISITIONS 141
11.4.4 AGREEMENTS AND PARTNERSHIPS 142
11.4.5 ANNOUNCEMENTS 143

12 COMPANY PROFILES 144
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
12.1 THERMO FISHER SCIENTIFIC INC. 144
12.2 ABCAM PLC 150
12.3 BIO-RAD LABORATORIES, INC. 154
12.4 PERKINELMER INC. 158
12.5 MERCK MILLIPORE 162
12.6 INOVA DIAGNOSTICS (A PART OF WERFERN COMPANY) 166
12.7 CELL SIGNALING TECHNOLOGY, INC. 168
12.8 MEDIPAN GMBH 171
12.9 SINO BIOLOGICAL INC. 173
12.10 DANAHER CORPORATION 176
12.11 VECTOR LABORATORIES (A PART OF MARAVAI LIFESCIENCES) 179
*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.
13 APPENDIX 183
13.1 DISCUSSION GUIDE 183
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 187
13.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 189
13.4 AVAILABLE CUSTOMIZATIONS 191
13.5 RELATED REPORTS 191
13.6 AUTHOR DETAILS 192

渋谷データカウント

渋谷データカウントは、最も信頼性が高く最新の調査分析レポートを確実に提供する経験豊富な調査専門家のグローバルチームが提供する、さまざまな業界のさまざまな市場調査レポートを提供する再販代理店です。

Recommended reports

+